Our results showed that BTN3A1 was lower in tumor samples than in counterpart normal controls in 46 (70.8%) of 65 NSCLCs (Table 1), detected by qPCR (Fig. 6A), western blot (Fig. 6B,C), and IHC (Fig. 6D,E). Here, BTN3A1 is linked to neoplasm.